Colgate-Palmolive Company (CL) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Colgate-Palmolive Company stock (CL) is currently trading at $85.49. Colgate-Palmolive Company PE ratio is 32.14. Colgate-Palmolive Company PS ratio (Price-to-Sales) is 3.32. Analyst consensus price target for CL is $97.26. WallStSmart rates CL as Hold.
- CL PE ratio analysis and historical PE chart
- CL PS ratio (Price-to-Sales) history and trend
- CL intrinsic value — DCF, Graham Number, EPV models
- CL stock price prediction 2025 2026 2027 2028 2029 2030
- CL fair value vs current price
- CL insider transactions and insider buying
- Is CL undervalued or overvalued?
- Colgate-Palmolive Company financial analysis — revenue, earnings, cash flow
- CL Piotroski F-Score and Altman Z-Score
- CL analyst price target and Smart Rating
Colgate-Palmolive Company
📊 No data available
Try selecting a different time range
CL Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Colgate-Palmolive Company (CL)
CL trades 280% above its Graham fair value of $22.51, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Colgate-Palmolive Company (CL) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, return on equity, operating margin. Concerns around peg ratio and price/book. Fundamentals are solid but monitor weak areas for improvement.
Colgate-Palmolive Company (CL) Key Strengths (4)
Every $100 of shareholder equity generates $50 in profit
86.30% of shares held by major funds and institutions
Large-cap company with substantial market presence
Strong operational efficiency: $20 kept per $100 revenue
Colgate-Palmolive Company (CL) Areas to Watch (6)
Very expensive relative to growth, significant premium
Very expensive at 1263.5x book value
Earnings barely growing at 1.10%
Modest revenue growth at 5.80%
Revenue is fairly priced at 3.32x sales
Decent profitability, keeps $11 per $100 revenue
Supporting Valuation Data
Colgate-Palmolive Company (CL) Detailed Analysis Report
Overall Assessment
This company scores 56/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 3.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Return on Equity, Institutional Own., Market Cap. Profitability is solid with Return on Equity at 49.70%, Operating Margin at 20.40%.
The Bear Case
The primary concerns are PEG Ratio, Price/Book, EPS Growth. Some valuation metrics including PEG Ratio (3.26), Price/Sales (3.32), Price/Book (1263.48) suggest expensive pricing. Growth concerns include Revenue Growth at 5.80%, EPS Growth at 1.10%, which may limit upside. Profitability pressure is visible in Profit Margin at 10.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether PEG Ratio improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 49.70% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 5.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, Institutional Own.) and negatives (PEG Ratio, Price/Book). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CL Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CL's Price-to-Sales ratio of 3.32x trades 29% below its historical average of 4.66x (6th percentile). The current valuation is 49% below its historical high of 6.58x set in Mar 2013, and 6% above its historical low of 3.15x in Jun 2013.
WallStSmart Analysis Synopsis
Data-driven financial summary for Colgate-Palmolive Company (CL) · CONSUMER DEFENSIVE › HOUSEHOLD & PERSONAL PRODUCTS
The Big Picture
Colgate-Palmolive Company operates as a stable business with moderate growth and solid fundamentals. Revenue reached 20.4B with 6% growth year-over-year. Profit margins of 10.5% are healthy, with room for further expansion as the business scales.
Key Findings
ROE of 49.7% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 1.3B in free cash flow and 1.5B in operating cash flow. Earnings are translating into actual cash generation.
Debt-to-equity ratio of 147.93 is elevated. High leverage amplifies both gains and losses and increases financial risk.
What to Watch Next
Margin expansion: can Colgate-Palmolive Company push profit margins above 15% as the business scales?
Debt management: total debt of 8.0B is significantly higher than cash (1.3B). Monitor refinancing risk.
Sector dynamics: monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive moves, and regulatory changes that could impact Colgate-Palmolive Company.
Bottom Line
Colgate-Palmolive Company offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(39 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 10:06:55 AM
About Colgate-Palmolive Company(CL)
NYSE
CONSUMER DEFENSIVE
HOUSEHOLD & PERSONAL PRODUCTS
USA
Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.